Scholarlink

Background <p>The toxicity of the contaminant N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine quinone (6-PPDQ) is a growing concern. However, its potential myocardial toxicity remains unclear. In this study, the impact of 6-PPDQ on myocardial tissue was investigated. Differential RNA expression profiles and metabolic patterns in myocardial tissues from 6-PPDQ–exposed and untreated mice were examined using whole-transcriptome sequencing and untargeted metabolomics based on RNA sequencing and ultra-high-performance liquid chromatography.</p> Results <p>Our results showed that 6-PPDQ induces myocardial damage by exacerbating pathological changes, elevating cardiac injury biomarker levels, and increasing cardiomyocyte apoptosis. Transcriptome analysis revealed differentially expressed long noncoding RNAs (501), circular RNAs (138), microRNAs (63), and mRNAs (4054) in the 6-PPDQ group compared with the controls. Metabolomic analysis revealed 208 differential metabolites, along with dysregulation of ABC transporters, the citrate cycle, and efferocytosis. Integrated whole-transcriptome and untargeted metabolomics profiling presented <i>Myl7</i>, <i>Orm1</i>, <i>Usp29</i>, and <i>Rxfp1</i> were participated in 6-PPDQ induces myocardial injury. Finally, Myl7 was identified as the potential candidate target of 6-PPDQ through molecular docking and expression analyses, and molecular dynamics (MD) simulations.</p> Conclusions <p>These findings collectively indicate that 6-PPDQ exacerbates cardiac damage partially through the dysregulation of Myl7 expression, highlighting the mechanisms underlying its myocardial toxicity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multidimensional measurement of 6-PPDQ exposure aggravates myocardial injury in mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月21日

查看全文
  • Huichao Pan,
  • Jun Zhou,
  • Lei Song,
  • Zhongqing Xu,
  • Min Zhang

摘要

Background

The toxicity of the contaminant N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine quinone (6-PPDQ) is a growing concern. However, its potential myocardial toxicity remains unclear. In this study, the impact of 6-PPDQ on myocardial tissue was investigated. Differential RNA expression profiles and metabolic patterns in myocardial tissues from 6-PPDQ–exposed and untreated mice were examined using whole-transcriptome sequencing and untargeted metabolomics based on RNA sequencing and ultra-high-performance liquid chromatography.

Results

Our results showed that 6-PPDQ induces myocardial damage by exacerbating pathological changes, elevating cardiac injury biomarker levels, and increasing cardiomyocyte apoptosis. Transcriptome analysis revealed differentially expressed long noncoding RNAs (501), circular RNAs (138), microRNAs (63), and mRNAs (4054) in the 6-PPDQ group compared with the controls. Metabolomic analysis revealed 208 differential metabolites, along with dysregulation of ABC transporters, the citrate cycle, and efferocytosis. Integrated whole-transcriptome and untargeted metabolomics profiling presented Myl7, Orm1, Usp29, and Rxfp1 were participated in 6-PPDQ induces myocardial injury. Finally, Myl7 was identified as the potential candidate target of 6-PPDQ through molecular docking and expression analyses, and molecular dynamics (MD) simulations.

Conclusions

These findings collectively indicate that 6-PPDQ exacerbates cardiac damage partially through the dysregulation of Myl7 expression, highlighting the mechanisms underlying its myocardial toxicity.